Related Experiment Video
Updated: Aug 16, 2026

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Safety of mifepristone abortions in clinical use
Jillian T Henderson1, Ann C Hwang, Cynthia C Harper
1Center for Reproductive Health Research & Policy, University of California, San Francisco, CA 94143, USA. hendersonj@obgyn.ucsf.edu
Objectives:
Extensive data from clinical trials document mifepristone's safety and efficacy for induced abortion, but less information is available about its safety in routine clinical use.
Methods:
Data on mifepristone abortion use from the Planned Parenthood Federation of America, the largest provider of mifepristone abortion in the United States, from 2001 through the first quarter of 2004 were collected using a centralized reporting system. Over the study period, 95,163 mifepristone abortions were provided. Reportable events are complications requiring inpatient or outpatient hospital treatment.
Results:
Overall, 2.2 per 1000 women (95% CI 1.9-2.5) experienced a complication, most commonly, heavy bleeding. Mifepristone abortion mortality is estimated to be 1.1 per 100,000 based on one death (95% CI 0.3-5.9).
Conclusions:
The safety of mifepristone is high; few serious medical complications occur in routine clinical use.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Intrauterine Drug Delivery Systems
Mitral Valve Prolapse III: Nursing Management
Birth Control Methods
Drugs for Treatment of Constipation-Predominant IBS
Drug Regulation